Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07456800 · ClinicalTrials.gov registry record · Phase 1
PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects
A Phase 1 study, sponsored by PureTech.
- Completed
- Registry status
- Phase 1
- Development phase
- 116
- Enrollment target
NCT07456800 is a Phase 1 study that has completed, run by PureTech. The registered enrollment target is 116 participants.
The verdict
NCT07456800, a Phase 1 study, has completed, sponsored by PureTech.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 116 participants
- Enrollment target
Study Summary
A three-part, randomized, double-blind study in healthy older adults to identify a dose of deupirfenidone for further clinical study.
Interventions
- DRUG Placebo
- DRUG Deupirfenidone
- DRUG Pirfenidone (PFD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2022-01-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07456800
The ClinicalTrials.gov registry entry for NCT07456800 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PureTech, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07456800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07456800 about?
NCT07456800 is a clinical study titled "PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects". A three-part, randomized, double-blind study in healthy older adults to identify a dose of deupirfenidone for further clinical study.
What is the current status of trial NCT07456800?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 116 participants. The study started on 2021-07-12. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT07456800?
The interventions under investigation include: Placebo (DRUG), Deupirfenidone (DRUG), Pirfenidone (PFD) (DRUG).
Who is sponsoring clinical trial NCT07456800?
This trial is sponsored by PureTech, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.